5-hydroxytryptamine (5-HT) cellular sequestration during chronic exposure delays 5-HT3 receptor resensitization due to Its subsequent release

J. Daniel Hothersall, Amy Alexander, Andrew J. Samson, Christopher Moffat, Karen A. Bollan, Christopher N. Connolly (Lead / Corresponding author)

    Research output: Contribution to journalArticle

    3 Citations (Scopus)
    140 Downloads (Pure)

    Abstract

    The serotonergic synapse is dynamically regulated by serotonin (5-hydroxytryptamine (5-HT)) with elevated levels leading to the down-regulation of the serotonin transporter and a variety of 5-HT receptors, including the 5-HT type-3 (5-HT3) receptors. We report that recombinantly expressed 5-HT3 receptor binding sites are reduced by chronic exposure to 5-HT (IC50 of 154.0 ± 45.7 μm, t½ = 28.6 min). This is confirmed for 5-HT3 receptor-induced contractions in the guinea pig ileum, which are down-regulated after chronic, but not acute, exposure to 5-HT. The loss of receptor function does not involve endocytosis, and surface receptor levels are unaltered. The rate and extent of down-regulation is potentiated by serotonin transporter function (IC50 of 2.3 ± 1.0 μm, t½ = 3.4 min). Interestingly, the level of 5-HT uptake correlates with the extent of down-regulation. Using TX-114 extraction, we find that accumulated 5-HT remains soluble and not membrane-bound. This cytoplasmically sequestered 5-HT is readily releasable from both COS-7 cells and the guinea pig ileum. Moreover, the 5-HT level released is sufficient to prevent recovery from receptor desensitization in the guinea pig ileum. Together, these findings suggest the existence of a novel mechanism of down-regulation where the chronic release of sequestered 5-HT prolongs receptor desensitization.
    Original languageEnglish
    Pages (from-to)32020-32029
    Number of pages10
    JournalJournal of Biological Chemistry
    Volume289
    Issue number46
    DOIs
    Publication statusPublished - 14 Nov 2014

    Fingerprint Dive into the research topics of '5-hydroxytryptamine (5-HT) cellular sequestration during chronic exposure delays 5-HT<sub>3</sub> receptor resensitization due to Its subsequent release'. Together they form a unique fingerprint.

  • Profiles

    Cite this